chr1-1013986-C-T
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 2P and 7B. PM2BP4_StrongBP6_ModerateBP7
The NM_005101.4(ISG15):c.6C>T(p.Gly2=) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_005101.4 splice_region, synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ISG15 | NM_005101.4 | c.6C>T | p.Gly2= | splice_region_variant, synonymous_variant | 2/2 | ENST00000649529.1 | NP_005092.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ISG15 | ENST00000649529.1 | c.6C>T | p.Gly2= | splice_region_variant, synonymous_variant | 2/2 | NM_005101.4 | ENSP00000496832 | P1 | ||
ISG15 | ENST00000624652.1 | c.-19C>T | splice_region_variant, 5_prime_UTR_variant | 3/3 | 3 | ENSP00000485313 | ||||
ISG15 | ENST00000624697.4 | c.-19C>T | splice_region_variant, 5_prime_UTR_variant | 3/3 | 3 | ENSP00000485643 |
Frequencies
GnomAD3 genomes Cov.: 35
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 35
ClinVar
Submissions by phenotype
Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 24, 2020 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.